[{"id":"2724193d-44df-4903-9b86-2f4db953b4cd","acronym":"","url":"https://clinicaltrials.gov/study/NCT06075849","created_at":"2023-11-19T04:16:12.935Z","updated_at":"2024-07-02T16:35:17.893Z","phase":"Phase 1","brief_title":"Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent","source_id_and_acronym":"NCT06075849","lead_sponsor":"Panolos Bioscience","biomarkers":" FLT1","pipe":"","alterations":" ","tags":["FLT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PB101"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 10/25/2023","start_date":" 10/25/2023","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 01/01/2025","study_completion_date":" 01/01/2025","last_update_posted":"2024-02-23"}]